CLA comprises a group of unsaturated FA isomers with a variety of biological effects in experimental animals. CLA reduces body fat accumulation in animal models and has been suggested to have significant effects on lipid and glucose metabolism, e.g., antidiabetic effects in obese Zucker rats. It has been proposed that the trans10-cis12 isomer is the active isomer associated with the antiobesity and insulin-sensitizing properties of CLA. The metabolic effects in humans in general, and isomer-specific effects specifically, are not well characterized. In a series of controlled studies in humans, we investigated the effects of CLA (given as the commercially available mixture of isomers and as the purified trans10-cis12 CLA isomer) on anthropometry, lipid and glucose metabolism, and markers of lipid peroxidation. Preliminary results indicate that CLA may slightly decrease body fat in humans also, particularly abdominal fat, but there is no effect on body weight or body mass index. There is no simultaneous improvement in lipid or glucose metabolism. Rather, the trans10-cis12 CLA isomer unexpectedly caused significant impairment of the peripheral insulin sensitivity as well as of blood glucose and serum lipid levels. In addition, CLA markedly elevated lipid peroxidation. Thus, the metabolic effects of CLA in human seem complex; further studies, especially of isomer-specific effects and for longer time periods, are warranted.
KeywordsLinoleic Acid Conjugate Linoleic Acid Conjugate Linoleic Acid Isomer Conjugate Linoleic Acid Supplementation Dietary Conjugate Linoleic Acid
body mass index
sagittal abdominal diameter
Unable to display preview. Download preview PDF.
- 1.Kepler, C.R., Hirons, K.P., McNeill, J.J., and Tove, S.B. (1966) Intermediates and Products of the Biohydrogenation of Linoleic Acid by Butyrivibrio fibrisolvens, J. Biol. Chem. 245, 3612–3620.Google Scholar
- 3.Briton, M., Fong, C., Wickens, D., and Yudkin, J. (1992) Diet as a Source of Phospholipid Esterified 9,11-Octadecadienoic Acid in Humans Clin. Sci. 83, 97–101.Google Scholar
- 9.Houseknecht, K.L., Van den Heuvel, J.P., Moya-Camarena, S.Y., Portocarrero, C.P., Peck, L.W., Nickel, K.P., and Belury, M. (1998) Dietary Conjugated Linoleic Acid Normalizes Impaired Glucose Tolerance in the Zucker Diabetic Fatty fa/fa Rat, Biochem. Biophys. Res. Commun. 244, 678–682.PubMedCrossRefGoogle Scholar
- 14.Pouliot, M.C., Després, J.P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., and Lupien, P.J. (1994) Waist Circumference and Sagittal Diameter: Best Simple Anthropometric Indexes of Abdominal Visceral Adipose Tissue Accumulation and Related Metabolic Cardiovascular Risk Factors in Men and Women, Am. J. Cardiol. 73, 460–468.PubMedCrossRefGoogle Scholar
- 16.Risérus, U., Berglund, L., and Vessby, B. (2001) Abdominal Sagittal Diameter Is Strongly Related to Insulin Resistance in Men with the Metabolic Syndrome, Diabetologia 44 (Suppl. 1), A205 (Abstr.).Google Scholar
- 18.Atkinson, R.L. (1999) Conjugated Linoleic Acid for Altering Body Composition and Treating Obesity, in Advances in Conjugated Linoleic Acid Research, Volume 1 (Yurawecz, M.P., Mossoba, M.M., Kramer, J.K.G.., Pariza, M.W., and Nelson, G.J., eds.) pp. 348–353, AOCS Press, Champaign.Google Scholar
- 34.Yudkin, J.S., Stehouwer, C.D., Emeis, J.J., and Coppack, S.W. (1999) C-Reactive Protein in Healthy Subjects: Associations with Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating from Adipose Tissue? Arterioscler. Thromb. Vasc. Biol. 19, 972–978.PubMedGoogle Scholar
- 36.Park, Y., Storkson, J.M., Albright, K.J., Liu, W., and Pariza, M.W. (1999) Evidence That the trans 10,cis12 Isomer of Conjugated Linoleic Acid Induces Body Weight Changes in Mice, Lipids 34, 234–241.Google Scholar
- 38.Ryder, J.W., Portocarrero, C.P., Song, X.M., Cui, L., Yu, M., Combatsiaris, T., Galuska, D., Bauman, D.E., Barbano, D.M., Charon, M.J., Zierath, J.R., and Houseknecht, K.L. (2001) Isomer-Specific Antidiabetic Properties of Conjugated Linoleic Acid. Improved Glucose Tolerance, Skeletal Muscle Insulin Action and UCP-2 Gene Expression, Diabetes 50, 1149–1157.PubMedGoogle Scholar